Does RITUXIMAB Cause Lymphocyte adoptive therapy? 8 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Lymphocyte adoptive therapy have been filed in association with RITUXIMAB (Rituxan). This represents 0.0% of all adverse event reports for RITUXIMAB.
8
Reports of Lymphocyte adoptive therapy with RITUXIMAB
0.0%
of all RITUXIMAB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Lymphocyte adoptive therapy From RITUXIMAB?
Of the 8 reports, 1 (12.5%) required hospitalization.
Is Lymphocyte adoptive therapy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXIMAB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXIMAB Cause?
Off label use (39,751)
Drug ineffective (32,186)
Rheumatoid arthritis (19,850)
Pain (16,675)
Fatigue (15,602)
Arthralgia (12,529)
Rash (12,102)
Drug intolerance (11,876)
Infusion related reaction (11,871)
Joint swelling (11,170)
What Other Drugs Cause Lymphocyte adoptive therapy?
AXICABTAGENE CILOLEUCEL (108)
CILTACABTAGENE AUTOLEUCEL (43)
LISOCABTAGENE MARALEUCEL (25)
BREXUCABTAGENE AUTOLEUCEL (22)
IBRUTINIB (18)
TISAGENLECLEUCEL (17)
IDECABTAGENE VICLEUCEL (13)
VENETOCLAX (9)
CYCLOPHOSPHAMIDE (8)
CISPLATIN (6)
Which RITUXIMAB Alternatives Have Lower Lymphocyte adoptive therapy Risk?
RITUXIMAB vs RITUXIMAB-ABBS
RITUXIMAB vs RITUXIMAB-ARRX
RITUXIMAB vs RITUXIMAB-PVVR
RITUXIMAB vs RIVAROXABAN
RITUXIMAB vs RIVASTIGMINE